Efficacy and safety of mirtazapine in patients with depression and insomnia

Efficacy and safety of mirtazapine in patients with depression and insomnia - Effects of mirtazapine on patients with depression and insomnia

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000005944

Enrollment

Registered

2011-08-01

Start date

2011-08-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

major depression

Interventions

administration of mirtazapine

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Major depressive disorder according to DSM-IV-TR

Exclusion criteria

Exclusion criteria: Comorbid other psychiatric disorders or physical disorders

Design outcomes

Primary

Measure	Time frame
Hamilton rating scale for depression	—

Secondary

Measure	Time frame
Visual analog scale for sleep quality	—

Countries

Japan

Contacts

Public ContactMakoto Uchiyama

Nihon University School of Medicine Department of Psychiatry

uchiyama.makoto@nihon-u.ac.jp03-3972-8111

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026